Chronic rhinosinusitis without nasal polyps

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
D Dermatology (ATC D) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 2 substances
Phase II: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Sanofi-Aventis Recherche & Developpement Commercial
    ITEPEKIMAB
    2024-515576-12-00 7 countries 2025 n=53
    Ended

Phase IV

1 trial
  • Medical University Of Vienna Academic
    DUPILUMAB
    2023-509815-10-00 1 country 2024 n=80
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Sanofi-Aventis Recherche & Developpement Commercial 1 Phase II 0
Medical University Of Vienna Academic 1 Phase IV 0
New trials by year
2024
1
2025
1
← All indication landscapes